Acne Vulgaris

Wearing a mask has become a normal aspect of life for many in the U.S. because of the COVID-19 pandemic. For many students going back to school, masks have been required for in-person instruction.

Wearing a mask is now mandated in many public areas across the country in an attempt to stem the spread of COVID-19.

In three phase 3 clinical trials, trifarotene 50 µg/g cream demonstrated efficacy and safety in the treatment of both facial and truncal acne, according to a poster presented at the American Academy of Dermatology virtual meeting.

Once-daily use of tazarotene 0.045% reduced inflammatory and noninflammatory acne vulgaris lesions, according to a phase 3 study presented at the American Academy of Dermatology virtual meeting.

Common medications to treat acne and other inflammatory dermatoses strongly associated with drug-induced intracranial hypertension include vitamin A derivatives, tetracycline-class antibiotics, recombinant growth hormone and lithium, according to a literature review to help guide dermatologists in a diagnostic and drug-causality algorithm.

Some preliminary evidence supports the use of zinc in the treatment of acne vulgaris and hidradenitis suppurativa, although further studies are necessary to evaluate zinc supplementation in treating inflammatory skin disease, according to a study.

NEWPORT BEACH, Calif. — The unmet needs in the medical aesthetics market currently reside in hair growth, skin tightening and texture, and acne device-based technologies, according to researchers here at a session on medical innovation in aesthetics.

The FDA has approved Amzeeq topical foam 4% for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older.

The FDA recently approved Galderma’s topical retinoid cream, known as Aklief, for the treatment of acne vulgaris.